Metabolism of prostaglandin Fin early human placenta in vitro

D. Falkay, M. Sas

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The authors were investigating the metabolism of prostaglandin F2α in human early placenta, in in vitro incubation experiments. They have identified both major metabolites, 15-keto-PGPGFand 15-keto-13, 14 dehydro PGPGF. They have examined the change in the percentage of these, taken as a function of time. They have established that the main site of inactivating the endogenous PGPGF, is the early human placenta. They suppose that the considerable Pg-inactiviting effect of the placenta has a part which acts as a protecting mechanism in preventing the uterotonic influence of the endogenous prostaglandins.

Original languageEnglish
Pages (from-to)99-106
Number of pages8
JournalHormone Research in Paediatrics
Volume8
Issue number2
DOIs
Publication statusPublished - 1977

Fingerprint

Placenta
Prostaglandins
Dinoprost
In Vitro Techniques

Keywords

  • Human placenta
  • In vitro
  • Metabolism
  • Prostaglandin F<inf>2α</inf>

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Pediatrics, Perinatology, and Child Health

Cite this

Metabolism of prostaglandin Fin early human placenta in vitro. / Falkay, D.; Sas, M.

In: Hormone Research in Paediatrics, Vol. 8, No. 2, 1977, p. 99-106.

Research output: Contribution to journalArticle

@article{39868f12f85c4fc7aa7a07f165cb9a5f,
title = "Metabolism of prostaglandin F2αin early human placenta in vitro",
abstract = "The authors were investigating the metabolism of prostaglandin F2α in human early placenta, in in vitro incubation experiments. They have identified both major metabolites, 15-keto-PGPGF2αand 15-keto-13, 14 dehydro PGPGF2α. They have examined the change in the percentage of these, taken as a function of time. They have established that the main site of inactivating the endogenous PGPGF2α, is the early human placenta. They suppose that the considerable Pg-inactiviting effect of the placenta has a part which acts as a protecting mechanism in preventing the uterotonic influence of the endogenous prostaglandins.",
keywords = "Human placenta, In vitro, Metabolism, Prostaglandin F<inf>2α</inf>",
author = "D. Falkay and M. Sas",
year = "1977",
doi = "10.1159/000178786",
language = "English",
volume = "8",
pages = "99--106",
journal = "Hormone Research in Paediatrics",
issn = "1663-2818",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Metabolism of prostaglandin F2αin early human placenta in vitro

AU - Falkay, D.

AU - Sas, M.

PY - 1977

Y1 - 1977

N2 - The authors were investigating the metabolism of prostaglandin F2α in human early placenta, in in vitro incubation experiments. They have identified both major metabolites, 15-keto-PGPGF2αand 15-keto-13, 14 dehydro PGPGF2α. They have examined the change in the percentage of these, taken as a function of time. They have established that the main site of inactivating the endogenous PGPGF2α, is the early human placenta. They suppose that the considerable Pg-inactiviting effect of the placenta has a part which acts as a protecting mechanism in preventing the uterotonic influence of the endogenous prostaglandins.

AB - The authors were investigating the metabolism of prostaglandin F2α in human early placenta, in in vitro incubation experiments. They have identified both major metabolites, 15-keto-PGPGF2αand 15-keto-13, 14 dehydro PGPGF2α. They have examined the change in the percentage of these, taken as a function of time. They have established that the main site of inactivating the endogenous PGPGF2α, is the early human placenta. They suppose that the considerable Pg-inactiviting effect of the placenta has a part which acts as a protecting mechanism in preventing the uterotonic influence of the endogenous prostaglandins.

KW - Human placenta

KW - In vitro

KW - Metabolism

KW - Prostaglandin F<inf>2α</inf>

UR - http://www.scopus.com/inward/record.url?scp=0017622475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017622475&partnerID=8YFLogxK

U2 - 10.1159/000178786

DO - 10.1159/000178786

M3 - Article

VL - 8

SP - 99

EP - 106

JO - Hormone Research in Paediatrics

JF - Hormone Research in Paediatrics

SN - 1663-2818

IS - 2

ER -